Overview Cocaine Opioid Oxytocin Option - Limited Status: Completed Trial end date: 2014-12-01 Target enrollment: Participant gender: Summary This is a pilot feasibility study assessing the tolerability of chronic administration of intranasal oxytocin to patients receiving methadone at an opioid replacement clinic who are actively using cocaine. Phase: Phase 1 Details Lead Sponsor: University of California, San FranciscoTreatments: CocaineOxytocin